Imperial College London

Dr Frédéric B. Piel

Faculty of MedicineSchool of Public Health

Senior Lecturer



+44 (0)20 7594 3346f.piel




Praed StreetSt Mary's Campus






BibTex format

author = {Lobitz, S and Telfer, P and Cela, E and Allaf, B and Angastiniotis, M and Backman, Johansson C and Badens, C and Bento, C and Bouva, MJ and Canatan, D and Charlton, M and Coppinger, C and Daniel, Y and de, Montalembert M and Ducoroy, P and Dulin, E and Fingerhut, R and Frömmel, C and García-Morin, M and Gulbis, B and Holtkamp, U and Inusa, B and James, J and Kleanthous, M and Klein, J and Kunz, JB and Langabeer, L and Lapouméroulie, C and Marcao, A and Marín, Soria JL and McMahon, C and Ohene-Frempong, K and Périni, J-M and Piel, FB and Russo, G and Sainati, L and Schmugge, M and Streetly, A and Tshilolo, L and Turner, C and Venturelli, D and Vilarinho, L and Yahyaoui, R and Elion, J and Colombatti, R and with, the endorsement of EuroBloodNet and the, European Reference Network in Rare Haematological Diseases},
doi = {10.1111/bjh.15600},
journal = {British Journal of Haematology},
pages = {648--660},
title = {Newborn screening for sickle cell disease in Europe: recommendations from a PanEuropean Consensus Conference},
url = {},
volume = {183},
year = {2018}

RIS format (EndNote, RefMan)

AB - Sickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. The aim of this paper is to summarise the discussions and present consensus recommendations which can be used to support development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.
AU - Lobitz,S
AU - Telfer,P
AU - Cela,E
AU - Allaf,B
AU - Angastiniotis,M
AU - Backman,Johansson C
AU - Badens,C
AU - Bento,C
AU - Bouva,MJ
AU - Canatan,D
AU - Charlton,M
AU - Coppinger,C
AU - Daniel,Y
AU - de,Montalembert M
AU - Ducoroy,P
AU - Dulin,E
AU - Fingerhut,R
AU - Frömmel,C
AU - García-Morin,M
AU - Gulbis,B
AU - Holtkamp,U
AU - Inusa,B
AU - James,J
AU - Kleanthous,M
AU - Klein,J
AU - Kunz,JB
AU - Langabeer,L
AU - Lapouméroulie,C
AU - Marcao,A
AU - Marín,Soria JL
AU - McMahon,C
AU - Ohene-Frempong,K
AU - Périni,J-M
AU - Piel,FB
AU - Russo,G
AU - Sainati,L
AU - Schmugge,M
AU - Streetly,A
AU - Tshilolo,L
AU - Turner,C
AU - Venturelli,D
AU - Vilarinho,L
AU - Yahyaoui,R
AU - Elion,J
AU - Colombatti,R
AU - with,the endorsement of EuroBloodNet
AU - the,European Reference Network in Rare Haematological Diseases
DO - 10.1111/bjh.15600
EP - 660
PY - 2018///
SN - 1365-2141
SP - 648
TI - Newborn screening for sickle cell disease in Europe: recommendations from a PanEuropean Consensus Conference
T2 - British Journal of Haematology
UR -
UR -
UR -
VL - 183
ER -